FIELD: medicine.
SUBSTANCE: what is presented is a method for determining indications for immune suppressive therapy following penetrating keratoplasty. Keratoplasty is preceded by determining a level of interleukin-2 (IL-2) in supernatants of recipient's lymphocyte cell cultures both stimulated and not stimulated by PHA; and the absence of a reliable difference in the IL-2 levels, the immune suppressive therapy is not considered to be indicated.
EFFECT: invention enables predicting a patient's preoperative immune response on a transplant and determining an adequacy of the immune suppressive therapy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF GRAFT VS HOST DISEASE FOLLOWING PENETRATING KERATOPLASTY | 2011 |
|
RU2472160C1 |
| METHOD FOR PREVENTING TRANSPLANTS'S DETACHMENT AFTER THROUGH KERATOPLASTY IN CHILDREN IN THE GROUP OF RISK | 2005 |
|
RU2297227C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF GRAFT DISEASE IN PATIENTS WITH THROUGH NATIVE DONOR CORNEAL GRAFT | 2023 |
|
RU2814632C1 |
| METHOD FOR EARLY DIAGNOSIS OF CORNEAL GRAFT REJECTION AFTER PENETRATING KERATOPLASTY | 2021 |
|
RU2770780C1 |
| PROLONGATION OF ALLOGRAFT SURVIVAL BY COMPLEMENT ACTIVITY INHIBITION | 2007 |
|
RU2445975C2 |
| MIC THERAPY FOR SPECIFIC IMMUNOSUPRESSION DURING TRANSPLANTATION | 2019 |
|
RU2806545C2 |
| METHOD OF DETECTING OF SPECIFICITY ACTIVATED LYMPHOCYTES AND ENVIRONMENT FOR ITS REALISATION | 2004 |
|
RU2343486C2 |
| METHOD FOR PREDICTION OF RISK OF COMPLICATIONS OF CADAVERIC LIVER TRANSPLANTATION IN RECIPIENTS | 2010 |
|
RU2424529C1 |
| METHOD FOR PREVENTION OF GRAFT KIDNEY GRAFT REJECTION | 2018 |
|
RU2688172C1 |
| METHOD OF DETERMINING SPECIFIC SENSITIZATION TO MEMBRANES OF EYE | 2023 |
|
RU2806032C1 |
